These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 2758765
21. Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable angina. Nidorf SM, Sturm M, Strophair J, Kendrew PJ, Taylor RR. Cardiovasc Res; 1989 Apr; 23(4):273-8. PubMed ID: 2590911 [Abstract] [Full Text] [Related]
22. Evidence for a role for Na+-H+ exchange in activation of human platelets by PAF. Sweatt JD, Schwartzberg MS, Frazer M, Cragoe EJ, Blair IA, Reed PW, Limbird LE. Circ Res; 1987 Nov; 61(5 Pt 2):II6-11. PubMed ID: 2822286 [Abstract] [Full Text] [Related]
23. At low extracellular calcium concentration platelet activating factor induces beta-thromboglobulin release from human platelets through thromboxane-endoperoxides formation. Zatta A, Zanetti A, Dejana E, Prosdocimi M. Agents Actions; 1987 Oct; 22(1-2):151-8. PubMed ID: 2961218 [Abstract] [Full Text] [Related]
27. Platelet-activating factor and not thromboxane A2 is an important mediator of endotoxin-induced platelet aggregation in equine heparinised whole blood in vitro. Jarvis GE, Evans RJ. Blood Coagul Fibrinolysis; 1996 Mar; 7(2):194-8. PubMed ID: 8735817 [Abstract] [Full Text] [Related]
28. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene. Lefort J, Rotilio D, Vargaftig BB. Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375 [Abstract] [Full Text] [Related]
32. The influence of PAF on the metabolization of arachidonic acid by human blood platelets. Ostermann G, Block HU, Till U. Biomed Biochim Acta; 1984 Jun 16; 43(8-9):S323-6. PubMed ID: 6440547 [Abstract] [Full Text] [Related]
34. Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin. Lauri D, Cerletti C, de Gaetano G. Agents Actions; 1986 Mar 16; 17(5-6):506-11. PubMed ID: 3706054 [Abstract] [Full Text] [Related]
35. Role of thromboxane A2. Ambler J, Birch J, Maguire ED, Wallis RB. Adv Exp Med Biol; 1985 Mar 16; 192():293-308. PubMed ID: 2939695 [No Abstract] [Full Text] [Related]
36. The roles of prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation in man and the rat. Emms H, Lewis GP. Br J Pharmacol; 1986 Jan 16; 87(1):109-15. PubMed ID: 3082399 [Abstract] [Full Text] [Related]
38. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets. Lin CH, Kuo SC, Huang LJ, Huang TF, Teng CM. Thromb Res; 1992 Apr 01; 66(1):61-73. PubMed ID: 1412184 [Abstract] [Full Text] [Related]
39. Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasma. Altman R, Scazziota A, Rouvier J, Cacchione R. Thromb Res; 1986 Jul 01; 43(1):103-11. PubMed ID: 3014677 [Abstract] [Full Text] [Related]
40. Why single daily dose of aspirin may not prevent platelet aggregation. Altman R, Scazziota A, Funes JC. Thromb Res; 1988 Aug 01; 51(3):259-66. PubMed ID: 3140408 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]